Nautilus Biotechnology, Inc.
NAUT · Laboratory Analytical Instruments
Latest available SEC filing: 10-Q ·
Latest disclosures
-
Latest financial period: Q3 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Posard Matthew L.: Form 4
Insider disclosure · Filed · Report period 18 Jun 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- NAUT · 63909J108 - Common Stock, par value $0.0001 per share
Company details and SEC sources
CIK 0001808805 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- NAUT on Nasdaq
- SEC industry group
- Laboratory Analytical Instruments (Industrial Applications and Services)
- Business address
- 2701 Eastlake Ave East, Seattle, WA, 98102
- Fiscal year end
- 31 December
- Former names on EDGAR
- ARYA Sciences Acquisition Corp III (to 08 Jun 2021)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields